Mark Burns is the founder of Aminex Therapeutics. Aminex Therapeutics has raised $4M in total funding. Latest round: Series A.
Mark Burns is the scientific founder of Aminex Therapeutics, a company where he led the discovery efforts for their AMXT 1501/DFMO assets. With over 20 years of experience in biotechnology, he holds a PhD from the University of Michigan and completed post-doctoral training at Rice University.
Full founder directory · Investor directory · Company funding database · Fundraising library